Marine Peptide-N6NH2 and Its Derivative-GUON6NH2 Have Potent Antimicrobial Activity Against Intracellular Edwardsiella tarda in vitro and in vivo

文献类型： 外文期刊

第一作者： Han, Huihui

作者： Han, Huihui;Teng, Da;Mao, Ruoyu;Hao, Ya;Yang, Na;Wang, Zhenlong;Li, Ting;Wang, Jianhua;Han, Huihui;Teng, Da;Mao, Ruoyu;Hao, Ya;Yang, Na;Wang, Zhenlong;Li, Ting;Wang, Xiumin;Wang, Jianhua;Wang, Xiumin

作者机构：

关键词： marine peptide; Edwardsiella tarda; intracellular activity; mechanism; macrophages

期刊名称：FRONTIERS IN MICROBIOLOGY （ 影响因子：4.235； 五年影响因子：4.926 ）

ISSN： 1664-302X

年卷期： 2021 年 12 卷

页码：

收录情况： SCI

摘要： Edwardsiella tarda is a facultative intracellular pathogen in humans and animals. There is no effective way except vaccine candidates to eradicate intracellular E. tarda. In this study, four derivatives of marine peptide-N6NH2 were designed by an introduction of unnatural residues or substitution of natural ones, and their intracellular activities against E. tarda were evaluated in macrophages and in mice, respectively. The minimum inhibitory concentration (MIC) value of N6NH2 and GUON6NH2 against E. tarda was 8 mu g/mL. GUON6NH2 showed higher stability to trypsin, lower toxicity (<1%) and longer post-antibiotic effect (PAE) than N6NH2 and other derivatives. Antibacterial mechanism results showed that GUON6NH2 could bind to LPS and destroyed outer/inner cell membranes of E. tarda, superior to N6NH2 and norfloxacin. Both N6NH2 and GUON6NH2 were internalized into macrophages mainly via lipid rafts, micropinocytosis, and microtubule polymerization, respectively, and distributed in the cytoplasm. The intracellular inhibition rate of GUON6NH2 against E. tarda was 97.05-100%, higher than that in case of N6NH2 (96.82-100%). In the E. tarda-induced peritonitis mouse model, after treatment with of 1 mu mol/kg N6NH2 and GUON6NH2, intracellular bacterial numbers were reduced by 1.54- and 1.97-Log(10) CFU, respectively, higher than norfloxacin (0.35-Log(10) CFU). These results suggest that GUON6NH2 may be an excellent candidate for novel antimicrobial agents to treat infectious diseases caused by intracellular E. tarda.

分类号：

  • 相关文献
作者其他论文 更多>>

微信小程序